Kestra Medical Technologies (NASDAQ:KMTS) CFO Vaseem Mahboob Sells 39,903 Shares of Stock

Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) CFO Vaseem Mahboob sold 39,903 shares of the stock in a transaction that occurred on Wednesday, October 28th. The stock was sold at an average price of $30.48, for a total value of $1,216,243.44. Following the completion of the transaction, the chief financial officer owned 60,609 shares in the company, valued at approximately $1,847,362.32. The trade was a 39.70% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link.

Vaseem Mahboob also recently made the following trade(s):

• On Tuesday, October 27th, Vaseem Mahboob sold 34,809 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $30.04, for a total value of $1,045,662.36.
• On Thursday, October 29th, Vaseem Mahboob sold 4,788 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $30.60, for a total transaction of $146,512.80.
• On Friday, August 7th, Vaseem Mahboob sold 26,287 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $25.88, for a total value of $680,307.56.
• On Tuesday, August 4th, Vaseem Mahboob sold 6,995 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $24.68, for a total value of $172,636.60.
• On Monday, August 3rd, Vaseem Mahboob sold 5,391 shares of Kestra Medical Technologies stock. The shares were sold at an average price of $23.80, for a total transaction of $128,305.80.
• On Friday, July 31st, Vaseem Mahboob sold 8,817 shares of Kestra Medical Technologies stock. The stock was sold at an average price of $22.61, for a total value of $199,352.37.

Kestra Medical Technologies Stock Performance

KMTS traded up $0.74 during trading hours on Thursday, hitting $30.61. The stock had a trading volume of 470,598 shares, compared to its average volume of 351,886. The company’s fifty day simple moving average is $26.59 and its 200 day simple moving average is $23.76. Kestra Medical Technologies, Ltd. has a 1 year low of $17.34 and a 1 year high of $31.04. The company has a quick ratio of 4.69, a current ratio of 4.69 and a debt-to-equity ratio of 0.33. The stock has a market cap of $1.82 billion, a PE ratio of -11.46 and a beta of 0.51.

Kestra Medical Technologies (NASDAQ:KMTS) last posted its earnings results on Monday, September 14th. The company reported ($0.75) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.61) by ($0.14). Kestra Medical Technologies had a negative net margin of 140.43% and a negative return on equity of 63.83%. The company had revenue of $30.97 million for the quarter. Equities analysts anticipate that Kestra Medical Technologies, Ltd. will post -2.45 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts recently issued reports on KMTS shares. BTIG Research restated a “buy” rating and set a $32.00 price target on shares of Kestra Medical Technologies in a research report on Tuesday, September 15th. Wolfe Research set a $30.00 price objective on shares of Kestra Medical Technologies in a research report on Wednesday, July 15th. Oppenheimer started coverage on Kestra Medical Technologies in a research report on Tuesday, July 21st. They set a “market perform” rating on the stock. Wall Street Zen downgraded Kestra Medical Technologies from a “hold” rating to a “sell” rating in a research note on Saturday, September 12th. Finally, Piper Sandler restated an “overweight” rating on shares of Kestra Medical Technologies in a research note on Tuesday, September 15th. Five research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $29.00.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of KMTS. Sterling Capital Management LLC lifted its holdings in shares of Kestra Medical Technologies by 834.0% in the 3rd quarter. Sterling Capital Management LLC now owns 878 shares of the company’s stock valued at $25,000 after acquiring an additional 784 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in Kestra Medical Technologies during the 3rd quarter valued at about $353,000. Quantinno Capital Management LP bought a new position in Kestra Medical Technologies in the 1st quarter valued at $431,000. California State Teachers Retirement System boosted its position in Kestra Medical Technologies by 39.2% in the 1st quarter. California State Teachers Retirement System now owns 27,835 shares of the company’s stock valued at $555,000 after buying an additional 7,844 shares during the period. Finally, Spartan Wealth Advisory Services LLC purchased a new stake in shares of Kestra Medical Technologies in the 1st quarter worth $603,000.

About Kestra Medical Technologies

Kestra Medical Technologies, Inc is a medical technology company focused on developing and commercializing wearable solutions for patients at risk of sudden cardiac arrest. Its primary product is the ASSURE wearable cardioverter defibrillator, a wearable device designed to continuously monitor a patient’s heart rhythm and deliver a therapeutic shock when clinically necessary.

The company’s platform combines cardiac monitoring, arrhythmia detection and defibrillation capabilities in a wearable system intended for use outside the hospital.